click below
click below
Normal Size Small Size show me how
Cardiovascular 3&4
| Brand | Generic | Pharmacologic Category | Indication | Essential Knowledge |
|---|---|---|---|---|
| Pradaxa | dabigatran (PO) | Anticoagulant, direct thrombin inhibitor | AF (stroke prevention), VTE (venous thromboembolism) | Key Side Effects: bleeding, dyspepsia US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patients undergoing spinal puncture Other Notes: swallow whole; dispense and store in original packaging; discard 4 months after opening |
| Eliquis | apixaban (PO) | Anticoagulant, factor Xa inhibitor | AF (stroke prevention), VTE | Key Side Effects: bleeding US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture |
| Xarelto | rivaroxaban (PO) | Anticoagulant, factor Xa inhibitor | AF (stroke prevention), VTE, PAD | Key Side Effects: bleeding US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture |
| Coumadin, Jantoven | warfarin (PO) | Anticoagulant, vitamin K antagonist | AF (stroke prevention), VTE | Key Side Effects: bleeding, skin necrosis US Boxed Warnings: bleeding risk Other Notes: narrow therapeutic index drug (toxicity may occur at concentrations close to therapeutic range; therapeutic monitoring recommended with INR) Other Notes: dose dependent tablet colors; consistent vitamin K intake recommended; many drug interactions |
| Lovenox | enoxaparin (SQ) | Anticoagulant, low molecular weight heparin | ACS, VTE | Key Side Effects: bleeding, HIT US Boxed Warnings: increased risk of epidural or spinal hematoma in patients undergoing spinal puncture Other Notes: do not expel air bubble from syringe prior to injection |
| --- | heparin (IV, SQ) | Anticoagulant | ACS, VTE | Key Side Effects: bleeding, hyperkalemia (chronic use), HIT |
| Plavix | clopidogrel (PO) | Antiplatelet agent | ACS, CAD, stroke | Key Side Effects: bleeding US Boxed Warnings: diminished effectiveness in poor metabolizers |
| Brilinta | ticagrelor (PO) | Antiplatelet agent | ACS | Key Side Effects: bleeding, dyspnea US Boxed Warnings: significant, sometimes fatal bleeding; do not exceed aspirin >100 mg daily due to reduced ticagrelor effectiveness |
| Bayer, Bufferin, Ecotrin | aspirin (PO) | Antiplatelet agent | ACS, stable angina, pain, stroke | Key Side Effects: dyspepsia, heartburn, bleeding Other Notes: CI in NSAID or salicylate allergy, children and teenagers with viral infection (due to Reye’s syndrome), can cause tinnitus in salicylate overdose |
| Nitrostat | nitroglycerin (SL) | Vasodilator | ACS, stable angina | Key Side Effects: headache, flushing, syncope, dizziness Other Notes: do not use with PDE-5 Inhibitors; tachyphylaxis (tolerance/ ↓ effectiveness); can aggravate angina causes by hypertrophic cardiomyopathy |
| Intracatheter: Cathflo, Activase IV: Activase | alteplase (intracatheter, IV) | Fibrinolytic | Intracatheter: catheter clearance IV: STEMI, acute ischemic stroke, PE | Key Side Effects: bleeding Other Notes: CI in patients with severe uncontrolled HTN |
| Pacerone, Nexterone | amiodarone (PO, IV) | Anti-arrhythmic | AF (rhythm control), ventricular fibrillation, ventricular tachycardia | Key Side Effects: hypothyroidism, hyperthyroidism, pulmonary toxicity, hepatotoxicity, epithelial keratopathy, photosensitivity US Boxed Warnings: intended only for life-threatening arrhythmias; pulmonary toxicity, hepatotoxicity; proarrhythmic Other Notes: many drug interactions |
| Zetia | ezetimibe (PO) | Cholesterol absorption inhibitor | Dyslipidemia | Key Side Effects: myalgias, diarrhea |
| Tricor, Trilipix | fenofibrate (PO) | Fibric acid derivative | Hypertriglyceridemia | Key Side Effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases |
| Lopid | gemfibrozil (PO) | Fibric acid derivative | Hypertriglyceridemia | Key Side Effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases |
| Lipitor | atorvastatin (PO) | HMG-CoA reductase inhibitor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding |
| Altoprev | lovastatin (PO) | HMG-CoA reductase inhibitor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding |
| Pravachol | pravastatin (PO) | HMG-CoA reductase inhibitor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding |
| Crestor | rosuvastatin (PO) | HMG-CoA reductase inhibitor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding |
| Zocor | simvastatin (PO) | HMG-CoA reductase inhibitor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding |
| Lovaza | omega-3 ethyl esters (PO) | Omega-3 fatty acids | Hypertriglyceridemia | Key Side Effects: dyspepsia, eructation, fishy aftertaste Other Notes: can prolong bleeding time when used with other medication that can increase bleeding risk, use caution with fish/shellfish allergy |
| Vascepa | icosapent ethyl (PO) | Omega-3 fatty acids | Hypertriglyceridemia | Key Side Effects: eructation, arthralgia Other Notes: can prolong bleeding time when used with other medication that can increase bleeding risk, use caution with fish/shellfish allergy |